West Pharmaceutical Services Inc Earnings Dividend

West Pharmaceutical Services Inc’s revenue jumped 21.01% since last year same period to $844.9Mn in the Q1 2026. On a quarterly growth basis, West Pharmaceutical Services Inc has generated 4.96% jump in its revenue since last 3-months.

West Pharmaceutical Services Inc’s net profit jumped 54.57% since last year same period to $138.8Mn in the Q1 2026. On a quarterly growth basis, West Pharmaceutical Services Inc has generated 5.07% jump in its net profits since last 3-months.

West Pharmaceutical Services Inc’s net profit margin jumped 27.73% since last year same period to 16.43% in the Q1 2026. On a quarterly growth basis, West Pharmaceutical Services Inc has generated 0.11% jump in its net profit margins since last 3-months.

West Pharmaceutical Services Inc’s price-to-earnings ratio after this Q1 2026 earnings stands at 43.09.

West Pharmaceutical Services Inc’s earning per share (EPS) estimates for the current quarter stand at 1.68 - a -8.4% fall from last quarter’s estimates.

West Pharmaceutical Services Inc’s earning per share (EPS) estimates for the current year stand at 1.68.

West Pharmaceutical Services Inc’s earning per share (EPS) jumped 46.9% since last year same period to 2.13 in the Q1 2026. This indicates that the West Pharmaceutical Services Inc has generated 46.9% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. West Pharmaceutical Services Inc’s return on assets (ROA) stands at 0.11.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. West Pharmaceutical Services Inc’s return on equity (ROE) stands at 0.19.

West Pharmaceutical Services Inc declared 0.22 dividend per share during the earnings announcement for Q1 2026.